Following coronary revascularisation surgery
Conditions
Interventions
Experimental Group:Standardized Western medical treatment + Standardized Baduanjin rehabilitation training
Control Group:Standardized Western medical treatment + Aerobic exercise training
Sponsors
The Third Affiliated Hospital of Zhejiang Chinese Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.Participants who meet the diagnostic criteria for coronary heart disease; 2.Participants who underwent successful percutaneous coronary intervention; 3.Participants aged between 18 and 80; 4.Participants of any gender; 5.Participants who have signed an informed consent form.
Exclusion criteria
Exclusion criteria: 1.Subjects with severe hepatic or renal impairment; 2.subjects with severe electrolyte disturbances; 3.subjects with severe haematological disorders or malignant tumours; 4.pregnant or breastfeeding women; 5.subjects with psychiatric disorders; 6.subjects with cognitive impairment (e.g. dementia, post-stroke cognitive impairment) that prevents them from understanding or carrying out exercise instructions; 7.Subjects scheduled to undergo repeat revascularisation surgery in the near future; 8.Subjects with other severe cardiovascular diseases such as uncontrolled hypertension, angina pectoris, rapid arrhythmias, high-degree or complete atrioventricular block (without a pacemaker), acute severe aortic stenosis, decompensated heart failure (NYHA Class IV), deep vein thrombosis, obstructive hypertrophic cardiomyopathy, acute pericarditis or myocarditis, acute endocarditis, or acute aortic dissection; 9.Participants with acute pulmonary embolism or chronic lung disease accompanied by symptoms of dyspnoea (occurring at rest or with minimal exertion); 10.Subjects with impaired limb mobility or who are unable to move independently; 11.Subjects with Shy-Drager syndrome; 12.Subjects who have participated in a clinical trial involving other drugs or exercise interventions within the past month; 13.Subjects deemed by the investigator to have other conditions rendering them unsuitable for participation in the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of major cardiovascular adverse events; | — |
Secondary
| Measure | Time frame |
|---|---|
| TCM Syndrome Score;Echocardiogram;Dynamic Electrocardiogram;Minnesota Quality of Life Scale;Cardiac enzymes;blood lipids;Blood Glucose; | — |
Countries
China
Contacts
Public ContactLiu Qiang
The Third Affiliated Hospital of Zhejiang Chinese Medical University
Outcome results
None listed